Sunshine Heart (SSH) Remains Neutral-Rated at BTIG; Commencement of New Trial w/ Same Device Questioned

Go back to Sunshine Heart (SSH) Remains Neutral-Rated at BTIG; Commencement of New Trial w/ Same Device Questioned

Sunshine Heart (SSH) PT Cut to $4 as Clinical Trials Stopped - Piper Jaffray

March 4, 2016 8:14 AM EST

Piper Jaffray analyst, Thomas Gunderson, maintained his Overweight rating but cut his PT to $4 from $10 on Sunshine Heart (NASDAQ: SSH) as clinical trials ceased to conserve cash. The analyst thinks SSH is taking a step back to increase the chances that the... More